Medication-overuse headache
Also known as: Medication overuse headache, MOH, Rebound headache, Analgesic-overuse headache
Medication-overuse headache is a secondary headache associated with frequent acute headache medication use, commonly occurring alongside migraine. Clinical management centres on medical assessment, a supervised medication plan, appropriate prevention, and relapse monitoring. Chinese-medicine care may provide adjunctive support for symptom management but must not replace medical oversight. While a review of chronic daily headache indicates potential acupuncture benefits, it does not establish specific efficacy for medication-overuse headache. A small retrospective Kampo study included affected patients, but its uncontrolled associations cannot establish benefit or validate the listed formulas. The menstrual migraine study is a protocol without results, and neuroimaging associations do not justify iron treatment. Pattern descriptions represent traditional clinical frameworks rather than validated biomedical subtypes.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a comprehensive headache diary documenting headache days, severity, functional impact, and every dose of acute medication, including over-the-counter and combination preparations.
- •Adhere to a consistent circadian routine, prioritising regular sleep-wake cycles, scheduled nutritional intake, and optimal hydration.
- •Evaluate daily caffeine consumption in consultation with a clinician; avoid abrupt, significant reduction if physiological dependence is suspected.
- •Implement gradual physical activity and relaxation techniques as tolerated; patients should avoid exertion during acute or severe pain episodes.
Cautions & Contraindications
- •Do not substitute acupuncture or herbs for a prescriber-led medication-overuse plan. Do not advise abrupt cessation of opioids or dependence-forming sedatives; withdrawal may need supervision. This is a general clinical precaution; the supplied studies do not test withdrawal protocols.[,]
- •Do not prescribe iron supplementation or chelation from the MRI findings: regional imaging associations neither diagnose systemic iron deficiency nor demonstrate benefit from iron-directed treatment.[]
- •Do not infer that the listed formulas are effective or safe with CGRP medicines from the retrospective Kampo report. It does not validate these particular prescriptions or exclude interactions; reconcile all medicines before herbal prescribing.[]
- •Use individual bleeding-risk, pregnancy and infection screening before needling. Avoid infected skin and unsafe anatomical trajectories. These are standard procedural precautions, not safety conclusions established by the supplied review abstract or trial protocol.[,]
When to reassess or seek care again
Coordinate initial medical review and reassess tolerability and medication-plan adherence within 1–2 weeks. Compare headache days, acute-medication days by drug class, average pain intensity and functional impact over successive 4-week periods. Review an adjunctive acupuncture trial at 4–6 weeks; stop or revise if there is no meaningful agreed improvement or adverse effects occur. Persistent overuse, unsuccessful withdrawal, escalating disability or suspected dependence warrants GP or headache-specialist review; red flags require immediate escalation. Continue relapse monitoring after improvement.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of clinical medicine · 2026
- Frontiers in neurology · 2026
- The journal of headache and pain · 2026
- Medical science monitor : international medical journal of experimental and clinical research · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
